Histone deacetylases, transcriptional control, and cancer

Journal of Cellular Physiology

Volumn 184, Issue 1, 2000, Pages 1-16

  Cress, W Douglas ^a   Seto, Edward ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CELL NUCLEUS RECEPTOR; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HORMONE RECEPTOR; HYBRID PROTEIN;

ACUTE LEUKEMIA; CANCER; CHROMATIN STRUCTURE; COLON CANCER; DNA METHYLATION; DNA PACKAGING; GENE CONTROL; GENE DISRUPTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; HISTONE DEACETYLASES; HISTONES; HUMANS; NEOPLASMS; RETINOBLASTOMA PROTEIN; TRANSCRIPTION, GENETIC;

APUS APUS; EUKARYOTA;

EID: 0034045040     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7     Document Type: Review

References (222)

1. Adnane J, Shao Z, Robbins PD. 1995. The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J Biol Chem 270:8837-8843.
2. Alland L, Muhle R, Hou H Jr, Potes J, Chin L, Schreiber-Agus N, DePinho RA. 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55.
3. Aravind L, Koonin EV. 1998. Second family of histone deacetylases. Science 280:1167.
4. Archer SY, Meng S, Shei A, Hodin RA. 1998. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95:6791-6796.
5. Ayer DE, Lawrence QA, Eisenman RN. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767-776.
6. Bach I, Rodriguez-Esteban C, Carriere C, Bhushan A, Krones A, Rose DW, Glass CK, Andersen B, Izpisua Belmonte JC, Rosenfeld MG. 1999. RLIM inhibits functional activity of LIM homeodomain transcription factors via recruitment of the histone deacetylase complex. Nat Genet 22:394-399.
7. Bakin AV, Curran T. 1999. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 283:387-390.
8. Baniahmad A, Kohne AC, Renkawitz R. 1992. A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor. EMBO J 11:1015-1023.
9. Bannister AJ, Kouzarides T. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641-643.
10. Barnard JA, Warwick G. 1993. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ 4:495-501.
11. Bartl S, Taplick J, Lagger G, Khier H, Kuchler K, Seiser C. 1997. Identification of mouse histone deacetylase 1 as a growth factor-inducible gene. Mol Cell Biol 17:5033-5043.
12. Beijersbergen RL, Kerkhoven RM, Zhu L, Carlee L, Voorhoeve PM, Bernards R. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev 8:2680-2690.
13. Bellacosa A, Cicchillitti L, Schepis F, Riccio A, Yeung AT, Matsumoto Y, Golemis EA, Genuardi M, Neri G. 1999. MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci USA 96:3969-3974.
14. Bhattacharya SK, Ramchandani S, Cervoni N, Szyf M. 1999. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397:579-583.
15. Boyes J, Byfield P, Nakatani Y, Ogryzko V. 1998. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396:594-598.
16. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601.
17. Brehm A, Miska E, Reid J, Bannister A, Kouzarides T. 1999a. The cell cycle-regulating transcription factors E2F-RB. Br J Cancer 80(Suppl 1):38-41.
18. Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. 1999b. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J 18: 2449-2458.
19. Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, Roth SY, Allis CD. 1996. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84:843-851.
20. Candau R, Zhou JX, Allis CD, Berger SL. 1997. Histone acetyltransferase activity and interaction with ADA2 are critical for GCN5 function in vivo. EMBO J 16:555-565.
21. Carmen AA, Rundlett SE, Grunstein M. 1996. HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex. J Biol Chem 271:15837-15844.
22. Chambon P. 1994. The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol 5:115-125.
23. Chen G, Fernandez J, Mische S, Courey AJ. 1999. A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. Genes Dev 13:2218-2230.
24. Chen JD, Evans RM. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
25. Claudio PP, Howard CM, Baldi A, DeLuca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B, Giordano A. 1994. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 54: 5556-5560.
26. Claudio P, Howard C, Fu Y, Cinti C, Califano L, Micheli P, Mercer E, Caputi M, Giordano A. 2000a. Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma. Cancer Res 60:8-12.
27. Claudio PP, Howard CM, Pacilio C, Cinti C, Romano G, Minimo C, Maraldi NM, Minna JD, Gelbert L, Leoncini L, Tosi GM, Hicheli P, Caputi M, Giordano GG, Giordano A. 2000b. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res 60:372-382.
28. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 10:1633-1644.
29. Cohen L, Richon V, Rifkind R, Marks P, Desai D, Amin S. 1998. Inhibition of N-methylnitrosourea-induced tumors by the cytodifferentiating agent, suberanilohydroxamic acid [abstract 736]. Proc Am Assoc Cancer Res 39:108.
30. Collins AF, Pearson HA, Giardina P, McDonagh KT, Brusilow SW, Dover GJ. 1995. Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. Blood 85:43-49.
31. Criqui-Filipe P, Ducret C, Maira SM, Wasylyk B. 1999. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. EMBO J 18:3392-3403.
32. Cross SH, Meehan RR, Nan X, Bird A. 1997. A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins. Nat Genet 16:256-259.
33. Dahl R, Kieslinger M, Beug H, Hayman MJ. 1998. Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling. Proc Natl Acad Sci USA 95:11187-11192.
34. Dang CV. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1-11.
35. Dangond F, Hafler DA, Tong JK, Randall J, Kojima R, Utku N, Gullans SR. 1998. Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells. Biochem Biophys Res Commun 242:648-652.
36. De Rubertis F, Kadosh D, Henchoz S, Pauli D, Reuter G, Struhl K, Spierer P. 1996. The histone deacetylase RPD3 counteracts genomic silencing in Drosophila and yeast. Nature 384:589-591.
37. Desai D, El-Bayoumy K, Amin S. 1999. Chemopreventative efficacy of suberanilohydroxamic acid (SAHA), a cytodifferentiating agent, against tobacco-specific nitrosamine 4-(methylinitros-amino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice [abstract 362]. Proc Am Assoc Cancer Res 40:2396.
38. Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM, Albagli O. 1998. The LAZ3(BCL-6) oncoprotein recruits a SMRT/ mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res 26:4645-4651.
39. Di Fiore B, Guarguaglini G, Palena A, Kerkhoven RM, Bernards R, Lavia P. 1999. Two E2F sites control growth-regulated and cell cycle-regulated transcription of the Htf9-a/RanBP1 gene through functionally distinct mechanisms. J Biol Chem 274:10339-10348.
40. Di Leonardo A, Linke SP, Clarkin K, Wahl GM. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8:2540-2551.
41. Dobrowolski SF, Stacey DW, Harter ML, Stine JT, Hiebert SW. 1994. An E2F dominant negative mutant blocks E1A induced cell cycle progression. Oncogene 9:2605-2612.
42. Doetzlhofer A, Rotheneder H, Lagger G, Koranda M, Kurtev V, Brosch G, Wintersberger E, Seiser C. 1999. Histone deacetylase 1 can repress transcription by binding to Sp1. Mol Cell Biol 19:5504-5511.
43. Dynlacht BD, Flores O, Lees JA, Harlow E. 1994. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev 8:1772-1786.
44. Dyson N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev 12:2245-2262.
45. Emiliani S, Fischle W, Van Lint C, Al-Abed Y, Verdin E. 1998. Characterization of a human RPD3 ortholog, HDAC3. Proc Natl Acad Sci USA 95:2795-2800.
46. Ewen ME, Xing YG, Lawrence JB, Livingston DM. 1991. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164.
47. Fenrick R, Hiebert SW. 1998. Role of histone deacetylases in acute leukemia. J Cell Biochem Suppl 31:194-202.
48. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A, Trouche D. 1998. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci USA 95:10493-10498.
49. Fischle W, Emiliani S, Hendzel MJ, Nagase T, Nomura N, Voelter W, Verdin E. 1999. A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J Biol Chem 274:11713-11720.
50. Futamura M, Monden Y, Okabe T, Fujita-Yoshigaki J, Yokoyama S, Nishimura S. 1995. Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells. Oncogene 10:1119-1123.
51. Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y, Nagase T, Yokoyama Y, Ohki M. 1998. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood 91:4028-4037.
52. Georgakopoulos T, Thireos G. 1992. Two distinct yeast transcriptional activators require the function of the GCN5 protein to promote normal levels of transcription. EMBO J 11:4145-4152.
53. Ghosh AK, Steele R, Ray RB. 1999. MBP-1 physically associates with histone deacetylase for transcriptional repression. Biochem Biophys Res Commun 260:405-409.
54. Ginsberg D, Vairo G, Chittenden T, Xiao ZX, Xu G, Wydner KL, DeCaprio JA, Lawrence JB, Livingston DM. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 8:2665-2679.
55. Glass CK, Holloway JM, Devary OV, Rosenfeld MG. 1988. The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 54:313-323.
56. Gobl AE, Berg M, Lopez-Egido JR, Oberg K, Skogseid B, Westin G. 1999. Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism. Biochim Biophys Acta 1447:51-56.
57. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG. 1998. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391:815-818.
58. Grozinger CM, Hassig CA, Schreiber SL. 1999. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci USA 96:4868-4873.
59. Gu W, Roeder RG. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606.
60. Gu W, Shi XL, Roeder RG. 1997. Synergistic activation of transcription by CBP and p53. Nature 387:819-823.
61. Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A. 1998. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91: 2634-2642.
62. Guo B, Odgren PR, van Wijnen AJ, Last TJ, Nickerson J, Penman S, Lian JB, Stein JL, Stein GS. 1995. The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc Natl Acad Sci USA 92:10526-10530.
63. Guy CT, Zhou W, Kaufman S, Robinson MO. 1996. E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol Cell Biol 16:685-693.
64. Hall M, Peters G. 1996. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68:67-108.
65. Hampsey M. 1997. A SAGA of histone acetylation and gene expression. Trends Genet 13:427-429.
66. Hannon GJ, Demetrick D, Beach D. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7:2378-2391.
67. Hassig CA, Fleischer TC, Billin AN, Schreiber SL Ayer, DE. 1997. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89:341-347.
68. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP. 1998. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. Nat Genet 18:126-135.
69. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48.
70. Helin K, Wu C-L, Lees JA, Dynlacht BD, Ngwu C, Harlow E. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative, trans-activation. Genes Dev 7:1850-1861.
71. Helin K, Holm K, Niebuhr A, Eiberg H, Tommerup N, Hougaard S, Poulsen HS, Spang-Thomsen M, Norgaard P. 1997. Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc Natl Acad Sci USA 94:6933-6938.
72. Hendrich B, Bird A. 1998. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18:6538-6547.
73. Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR. 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6:177-185.
74. Hijmans EM, Voorhoeve PM, Beijersbergen RL, van 't Veer LJ, Bernards R. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol Cell Biol 15:3082-3089.
75. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
76. Hsieh JJ, Zhou S, Chen L, Young DB, Hayward SD. 1999. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc Natl Acad Sci USA 96:23-28.
77. Huang EY, Zhang J, Miska EA, Guenther MG, Kouzarides T, Lazar MA. 2000. Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev 14:45-54.
78. Huang S, Lee WH, Lee EY. 1991. A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product. Nature 350:160-162.
79. Huang Y, Myers SJ, Dingledine R. 1999. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nat Neurosci 2:867-872.
80. Hurford RK Jr, Cobrinik D, Lee MH, Dyson N. 1997. pRB and p107/ p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 11:1447-1463.
81. Iavarone A, Massague J. 1999. E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest. Mol Cell Biol 19:916-922.
82. Inouye CJ, Seto E. 1994. Relief of YY1-induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. J Biol Chem 269:6506-6510.
83. Ishizaki J, Nevins JR, Sullenger BA. 1996. Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function. Nat Med 2:1386-1389.
84. Janknecht R, Hunter T. 1996. Transcription: a growing coactivator network [news; comment]. Nature 383:22-23.
85. Johnson CA, Barlow AL, Turner BM. 1998. Molecular cloning of Drosophila melanogaster cDNAs that encode a novel histone deacetylase dHDAC3. Gene 221:127-134.
86. Johnson DG, Cress WD, Jakoi L, Nevins JR. 1994a. Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci USA 91:12823-12827.
87. Johnson DG, Ohtani K, Nevins JR. 1994b. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 8:1514-1525.
88. Johnson DG, Schneider-Broussard R. 1998. Role of E2F in cell cycle control and cancer. Front Biosci 3:447-448.
89. Jones PA, Laird PW. 1999. Cancer epigenetics comes of age. Nat Genet 21:163-167.
90. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19: 187-191.
91. Jooss K, Lam EW, Bybee A, Girling R, Muller R, La Thangue NB. 1995. Proto-oncogenic properties of the DP family of proteins. Oncogene 10:1529-1536.
92. Kadosh D, Struhl K. 1997. Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters. Cell 89:365-371.
93. Kaelin WG Jr, Pallas DC, DeCaprio JA, Kaye FJ, Livingston DM. 1991. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64:521-532.
94. Kao HY, Downes M, Ordentlich P, Evans RM. 2000. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev 14:55-66.
95. Kehle J, Beuchle D, Treuheit S, Christen B, Kennison JA, Bienz M, Muller J. 1998. dMi-2, a hunchback-interacting protein that functions in polycomb repression. Science 282:1897-1900.
96. Kijima M, Yoshida M, Sugita K, Horinouchi S, Beppu T. 1993. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J Biol Chem 268:22429-22435.
97. Kim GD, Choi YH, Dimtchev A, Jeong SJ, Dritschilo A, Jung M. 1999a. Sensing of ionizing radiation-induced DNA damage by ATM through interaction with histone deacetylase. J Biol Chem 274: 31127-31130.
98. Kim J, Sif S, Jones B, Jackson A, Koipally J, Heller E, Winandy S, Viel A, Sawyer A, Ikeda T, Kingston R, Georgopoulos K. 1999b. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10:345-355.
99. Kitabayashi I, Yokoyama A, Shimizu K, Ohki M. 1998. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J 17:2994-3004.
100. Koipally J, Renold A, Kim J, Georgopoulos K. 1999. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J 18:3090-3100.
101. Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454.
102. Ladomery M, Lyons S, Sommerville J. 1997. Xenopus HDm, a maternally expressed histone deacetylase, belongs to an ancient family of acetyl-metabolizing enzymes. Gene 198:275-280.
103. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN. 1997. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349-356.
104. Laherty CD, Billin AN, Lavinsky RM, Yochum GS, Bush AC, Sun JM, Mullen TM, Davie JR, Rose DW, Glass CK, Rosenfeld MG, Ayer DE, Eisenman RN. 1998. SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors. Mol Cell 2:33-42.
105. Lai A, Lee JM, Yang WM, DeCaprio JA, Kaelin WG Jr, Seto E, Branton PE. 1999. RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol Cell Biol 19:6632-6641.
106. Lam EW, Watson RJ. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J 12: 2705-2713.
107. Lam EW, Bennett JD, Watson RJ. 1995. Cell-cycle regulation of human B-myb transcription. Gene 160:277-281.
108. Lee EY-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, Herrup K, Lee W-H, Bradley A. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and hematopoieses. Nature 359:288-294.
109. Lee JS, Galvin KM, See RH, Eckner R, Livingston D, Moran E, Shi Y. 1995. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev 9:1188-1198.
110. Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, Jacks T. 1996. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev 10:1621-1632.
111. Lenny N, Westendorf JJ, Hiebert SW. 1997. Transcriptional regulation during myelopoiesis. Mol Biol Rep 24:157-168.
112. Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A. 1992. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69:905-914.
113. Li Y, Turck CM, Teumer JK, Stavnezer E. 1986. Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene. J Virol 57:1065-1072.
114. Li Y, Graham C, Lacy S, Duncan AM, Whyte P. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7:2366-2377.
115. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM. 1998. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391:811-814.
116. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. 1997. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389:251-260.
117. Luo RX, Postigo AA, Dean DC. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473.
118. Lusser A, Brosch G, Loidl A, Haas H, Loidl P. 1997. Identification of maize histone deacetylase HD2 as an acidic nucleolar phosphoprotein. Science 277:88-91.
119. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW. 1998. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 18:7176-7184.
120. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A. 1998a. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-605.
121. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Trouche D, Harel-Bellan A. 1998b. Histone deacetylase and retinoblastoma protein. Bull Cancer 85:606-607.
122. Mahlknecht U, Hoelzer D, Bucala R, Verdin E. 1999. Cloning and characterization of the murine histone deacetylase (HDAC3). Biochem Biophys Res Commun 263:482-490.
123. Marcus GA, Silverman N, Berger SL, Horiuchi J, Guarente L. 1994. Functional similarity and physical association between GCN5 and ADA2: putative transcriptional adaptors. EMBO J 13:4807-4815.
124. Mayol X, Grana X, Baldi A, Sang N, Hu Q, Giordano A. 1993. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8:2561-2566.
125. McArthur GA, Laherty CD, Queva C, Hurlin PJ, Loo L, James L, Grandori C, Gallant P, Shiio Y, Hokanson WC, Bush AC, Cheng PF, Lawrence QA, Pulverer B, Koskinen PJ, Foley KP, Ayer DE, Eisenman RN. 1998. The Mad protein family links transcriptional repression to cell differentiation. Cold Spring Harb Symp Quant Biol 63:423-433.
126. McBain JA, Eastman A, Nobel CS, Mueller GC. 1997. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol 53:1357-1368.
127. McIntyre A, Young GP, Taranto T, Gibson PR, Ward PB. 1991. Different fibers have different regional effects on luminal contents of rat colon. Gastroenterology 101:1274-1281.
128. McIntyre A, Gibson PR, Young GP. 1993. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34:386-391.
129. McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD. 1998. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94:363-374.
130. McMahon SB, Wood MA, Cole MD. 2000. The essential cofactor TRRAP recruits the histone acetyltransferase hGCNS to c-Myc. Mol Cell Biol 20:556-562.
131. Meehan RR, Lewis JD, McKay S, Kleiner EL, Bird AP. 1989. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58:499-507.
132. Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, Kouzarides T. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J 18:5099-5107.
133. Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ, George DL. 1999. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 13:2490-2501.
134. Nan X, Campoy FJ, Bird A. 1997. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88:471-481.
135. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389.
136. Nevins JR. 1994. Cell cycle targets of the DNA tumor viruses. Curr Opin Genet Dev 4:130-134.
137. Nevins JR. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ 9:585-593.
138. Ng HH, Zhang Y, Hendrich B, Johnson CA, Turner BM, Erdjument-Bromage H, Tempst P, Reinberg D, Bird A. 1999. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet 23:58-61.
139. Nomura T, Khan MM, Kaul SC, Dong HD, Wadhwa R, Colmenares C, Kohno I, Ishii S. 1999. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev 13:412-423.
140. Nucifora G, Rowley JD. 1995. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1-14.
141. Ogryzko VV, Hirai TH, Russanova VR, Barbie DA, Howard BH. 1996a. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol Cell Biol 16:5210-5218.
142. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. 1996b. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
143. Parthun MR, Widom J, Gottschling DE. 1996. The major cytoplasmic histone acetyltransferase in yeast: links to chromatin replication and histone metabolism. Cell 87:85-94.
144. Phelps WC, Bagchi S, Barnes JA, Raychaudhuri P, Kraus V, Munger K, Howley PM, Nevins JR. 1991. Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. J Virol 65:6922-6930.
145. Pierce AM, Fisher SM, Conti CJ, Johnson DG. 1998a. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene 16:1267-1276.
146. Pierce AM, Gimenez-Conti IB, Schneider-Broussard R, Martinez LA, Conti CJ, Johnson DG. 1998b. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci USA 95:8858-8863.
147. Qian YW, Lee EY. 1995. Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast. J Biol Chem 270:25507-25513.
148. Qian YW, Wang YC, Hollingsworth RE Jr, Jones D, Ling N, Lee EY. 1993. A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature 364:648-652.
149. Qin XQ, Chittenden T, Livingston DM, Kaelin WG Jr. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 6:953-964.
150. Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA, Marks PA. 1996. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc Natl Acad Sci USA 93:5705-5708.
151. Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA, Marks PA. 1998. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci USA 95:3003-3007.
152. Riggs MG, Whittaker RG, Neumann JR, Ingram VM. 1977. n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 268:462-464.
153. Ross JF, Liu X, Dynlacht BD. 1999. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol Cell 3:195-205.
154. Rundlett SE, Carmen AA, Kobayashi R, Bavykin S, Turner BM, Grunstein M. 1996. HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc Natl Acad Sci USA 93:14503-14508.
155. Saito M, Helin K, Valentine MB, Griffith BB, Willman CL, Harlow E, Look AT. 1995. Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line. Genomics 25:130-138.
156. Samid D, Hudgins WR, Shack S, Liu L, Prasanna P, Myers CE. 1997. Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers. Adv Exp Med Biol 400A:501-505.
157. Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, Chen A, Weinberg RA. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci USA 92:2403-2407.
158. Sartorelli V, Puri PL, Hamamori Y, Ogryzko V, Chung G, Nakatani Y, Wang JY, Kedes L. 1999. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol Cell 4:725-734.
159. Sasaki S, Lesoon-Wood LA, Dey A, Kuwata T, Weintraub BD, Humphrey G, Yang WM, Seto E, Yen PM, Howard BH, Ozato K. 1999. Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin beta gene. EMBO J 18:5389-5398.
160. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ. 1998. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76:652-658.
161. Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi AI, DePinho RA. 1995. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80:777-786.
162. Sealy L, Chalkley R. 1978. The effect of sodium butyrate on histone modification. Cell 14:115-121.
163. Sears R, Ohtani K, Nevins JR. 1997. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol Cell Biol 17:5227-5235.
164. Sellers WR, Kaelin WG Jr. 1997. Role of the retinoblastoma protein in the pathogenesis of human cancer. J Clin Oncol 15:3301-3312.
165. Sellers WR, Rodgers JW, Kaelin WG Jr. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad Sci USA 92:11544-11548.
166. Shi Y, Mello C. 1998. A CBP/p300 homolog specifies multiple differentiation pathways in Caenorhabditis elegans. Genes Dev 12:943-955.
167. Siegfried Z, Cedar H. 1997. DNA methylation: a molecular lock. Curr Biol 7:R305-R307.
168. Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi BZ, Cedar H. 1999. DNA methylation represses transcription in vivo. Nat Genet 22:203-206.
169. Singh P, Wong SH, Hong W. 1994. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J 13:3329-3338.
170. Souza RF, Yin J, Smolinski KN, Zou TT, Wang S, Shi YQ, Rhyu MG, Cottrell J, Abraham JM, Biden K, Simms L, Leggett B, Bova GS, Frank T, Powell SM, Sugimura H, Young J, Harpaz N, Shimizu K, Matsubara N, Meltzer SJ. 1997. Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors. Cancer Res 57:2350-2353.
171. Sowa Y, Orita T, Minamikawa S, Nakano K, Mizuno T, Nomura H, Sakai T. 1997. Histone deacetylase inhibitor activates the WAF1/ Cip1 gene promoter through the Sp1 sites. Biochem Biophys Res Commun 241:142-150.
172. Sowa Y, Orita T, Minamikawa-Hiranabe S, Mizuno T, Nomura H, Sakai T. 1999. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res 59:4266-4270.
173. Stiegler P, De Luca A, Bagella L, Giordano A. 1998. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. Cancer Res 58:5049-5052.
174. Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, Frommer M, Clark SJ. 1997. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 57: 2229-2237.
175. Struhl K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12:599-606.
176. Sun ZW, Hampsey M. 1999. A general requirement for the Sin3-rpd3 histone
177. Takami Y, Kikuchi H, Nakayama T. 1999. Chicken histone deacetylase-2 controls the amount of the IgM H-chain at the steps of both transcription of its gene and alternative processing of its pre-mRNA in the DT40 cell line. J Biol Chem 274:23977-23990.
178. Targoff IN, Reichlin M. 1985. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 28:796-803.
179. Taunton J, Hassig CA, Schreiber SL. 1996. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272:408-411.
180. Taya Y. 1997. RB kinases and RB-binding proteins: new points of view. Trends Biochem Sci 22:14-17.
181. Thomas MJ, Seto E. 1999. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236: 197-208.
182. Tokitou F, Nomura T, Khan MM, Kaul SC, Wadhwa R, Yasukawa T, Kohno I, Ishii S. 1999. Viral ski inhibits retinoblastoma protein (Rb)-mediated transcriptional repression in a dominant negative fashion. J Biol Chem 274:4485-4488.
183. Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL. 1998. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395:917-921.
184. Trock B, Lanza E, Greenwald P. 1990a. Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst 82:650-661.
185. Trock BJ, Lanza E, Greenwald P. 1990b. High fiber diet and colon cancer: a critical review. Prog Clin Biol Res 346:145-157.
186. van der Vlag J, Otte AP. 1999. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat Genet 23:474-478.
187. Vassilev A, Yamauchi J, Kotani T, Prives C, Avantaggiati ML, Qin J, Nakatani Y. 1998. The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily. Mol Cell 2:869-875.
188. Verdel A, Khochbin S. 1999. Identification of a new family of higher eukaryotic histone deacetylases: coordinate expression of differentiation-dependent chromatin modifiers. J Biol Chem 274:2440-2445.
189. Verreault A, Kaufman PD, Kobayashi R, Stillman B. 1996. Nucleosome assembly by a complex of CAF-1 and acetylated histones H3/H4. Cell 87:95-104.
190. Verreault A, Kaufman PD, Kobayashi R, Stillman B. 1998. Nucleosomal DNA regulates the core-histone-binding subunit of the human Hat1 acetyltransferase. Curr Biol 8:96-108.
191. Vidal M, Gaber RF. 1991. RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae. Mol Cell Biol 11:6317-6327.
192. Vidal M, Braun P, Chen E, Boeke JD, Harlow E. 1996. Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. Proc Natl Acad Sci USA 93:10321-10326.
193. Wade PA, Jones PL, Vermaak D, Veenstra GJ, Imhof A, Sera T, Tse C, Ge H, Shi YB, Hansen JC, Wolffe AP. 1998a. Histone deacetylase directs the dominant silencing of transcription in chromatin: association with MeCP2 and the Mi-2 chromodomain SWI/SNF ATPase. Cold Spring Harb Symp Quant Biol 63:435-445.
194. Wade PA, Jones PL, Vermaak D, Wolffe AP. 1998b. A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase. Curr Biol 8:843-846.
195. Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, Th'ng J, Han J, Yang XJ. 1999. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 19:7816-7827.
196. Wang J, Helin C, Jin P, Nadal-Ginard B. 1995. Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1. Cell Growth Differ 6:1299-1306.
197. Weintraub SJ, Prater CA, Dean DC. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259-261.
198. Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, Dean DC. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812-815.
199. Whitehead RH, Young GP, Bhathal PS. 1986. Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut 27:1457-1463.
200. Woodage T, Basrai MA, Baxevanis AD, Hieter P, Collins FS. 1997. Characterization of the CHD family of proteins. Proc Natl Acad Sci USA 94:11472-11477.
201. Wotton D, Lo RS, Lee S, Massague J. 1999. A Smad transcriptional corepressor. Cell 97:29-39.
202. Wu CL, Classon M, Dyson N, Harlow E. 1996. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Mol Cell Biol 16:3698-3706.
203. Xiao H, Hasegawa T, Miyaishi O, Ohkusu K, Isobe K. 1997. Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21WAF/CIP1 in p53-independent manner. Biochem Biophys Res Commun 237:457-460.
204. Xiao H, Hasegawa T, Isobe K. 1999. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. J Cell Biochem 73:291-302.
205. Xu G, Livingston DM, Krek W. 1995. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci USA 92:1357-1361.
206. Yang WM, Inouye C, Zeng Y, Bearss D, Seto E. 1996a. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci USA 93:12845-12850.
207. Yang WM, Yao YL, Sun JM, Davie JR, Seto E. 1997. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J Biol Chem 272: 28001-28007.
208. Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y. 1996b. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319-324.
209. Yarden RI, Brody LC. 1999. BRCA1 interacts with components of the histone deacetylase complex. Proc Natl Acad Sci USA 96:4983-4988.
210. Yoshida H, Sugita K. 1992. A novel tetracyclic peptide, trapoxin, induces phenotypic change from transformed to normal in sis-oncogene-transformed NIH3T3 cells. Jpn J Cancer Res 83:324-328.
211. Yoshida M, Kijima M, Akita M, Beppu T. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265:17174-17179.
212. Yoshitaka T, Matsubara N, Ikeda M, Tanino M, Hanafusa H, Tanaka N, Shimizu K. 1996. Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability. Biochem Biophys Res Commun 227:553-557.
213. Zamir I, Harding HP, Atkins GB, Horlein A, Glass CK, Rosenfeld MG, Lazar MA. 1996. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol 16:5458-5465.
214. Zhang HS, Postigo AA, Dean DC. 1999a. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell 97:53-61.
215. Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P, Reinberg D. 1997. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89:357-364.
216. Zhang W, Bieker JJ. 1998. Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc Natl Acad Sci USA 95:9855-9860.
217. Zhang Y, LeRoy G, Seelig HP, Lane WS, Reinberg D. 1998a. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 95:279-289.
218. Zhang Y, Sun ZW, Iratni R, Erdjument-Bromage H, Tempst P, Hampsey M, Reinberg D. 1998b. SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex. Mol Cell 1:1021-1031.
219. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. 1999b. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13:1924-1935.
220. Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston DM, Dyson N, Harlow E. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7:1111-1125.
221. Zhu L, Enders G, Lees JA, Beijersbergen RL, Bernards R, Harlow E. 1995. The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J 14:1904-1913.
222. Zwicker J Liu N, Engeland K Lucibello FC, Muller R. 1996. Cell cycle regulation of E2F site occupation in vivo. Science 271:1595-1597.